• Publications
  • Influence

Claim Your Author Page
Ensure your research is discoverable on Semantic Scholar. Claiming your author page allows you to personalize the information displayed and manage publications (all current information on this profile has been aggregated automatically from publisher and metadata sources).
  • Luísa Costa, Francesco Caso, +8 authors Raffaele Scarpa
  • Medicine
  • Clinical Rheumatology
  • 2013 (First Published: 20 August 2013)
  • Psoriatic arthritis (PsA) is a chronic inflammatory condition, characterized by an excess of metabolic disorders. Metabolic syndrome (MetS) is a cluster of classic cardiovascular risk factors, due toContinue Reading
  • Roberta Ramonda, Massimo Puato, +11 authors Andrea Doria
  • Medicine
  • Joint, bone, spine : revue du rhumatisme
  • 2014 (First Published: 1 October 2014)
  • OBJECTIVE To evaluate the progression of subclinical atherosclerosis in Psoriatic Arthritis (PsA) patients treated with anti-tumor necrosis factor (TNF)-α agents. METHODS Thirty-two PsA patientsContinue Reading
  • Mariagrazia Lorenzin, Augusta Ortolan, Paola Frallonardo, Francesca Oliviero, Leonardo Punzi, Roberta Ramonda
  • Medicine
  • BMC Musculoskeletal Disorders
  • 2015 (First Published: 1 December 2015)
  • BackgroundThe advent of anti-tumor necrosis factor-α (TNFα) drugs has changed the course of ankylosing spondylitis (AS). While data are available concerning the long term effectiveness of singleContinue Reading
  • Manouk de Hooge, Roberta Ramonda, +4 authors Andrea Doria
  • Medicine
  • Arthritis Research & Therapy
  • 2016 (First Published: 1 December 2016)
  • BackgroundSpondyloarthritis often affects young people, typically in their working years. The aim of our study was to investigate work productivity and its relationship with disease activity andContinue Reading
  • Mariagrazia Lorenzin, Augusta Ortolan, +6 authors Roberta Ramonda
  • Medicine
  • International journal of immunopathology and…
  • 2015 (First Published: 1 December 2015)
  • Anti-tumor necrosis factor (TNF) alpha therapy has changed the course of psoriatic arthritis (PsA), but clinical experience about lengthening of time intervals between drug administrations is stillContinue Reading